Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR

Chinese Journal of Cancer

Volumn 28, Issue 2, 2009, Pages 97-99

  Zhang, Ye ^a   Qu, Xiu Juan ^a   Liu, Yun Peng ^a   Yang, Xiang Hong ^a   Hou, Ke Zuo ^a   Teng, Yue E ^a   Zhang, Jing Dong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric neoplasm; K562 DNR cell; Leukemia; Multidrug resistance; PI3 K Akt; SGC7901 ADR cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; PROTEIN KINASE B; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMONES; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; K562 CELLS; LEUKEMIA; MORPHOLINES; P-GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; STOMACH NEOPLASMS; VINCRISTINE;

EID: 70349509846     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein) [J]. Oncologist, 2007,12(8):927-941.
2. Fujita T, Washio K, Takabatake D, et al. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance [J]. Int J Cancer, 2005,117(4):670-682.
3. Shinoda C, Maruyama M, Fujishita T, et al. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway [J]. Int J Cancer, 2005,117(1):21-31.
4. Shi XY, Cai XJ, Lei JX, et al. Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol [J]. Ai Zheng, 2008,27(4):343-347.
5. Lee JT Jr, Steelman LS, McCubrey JA. Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells [J]. Cancer Res, 2004,64(22):8397-8404.
6. Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3-K/Akt/NF kappa B pathway [J]. Cancer Lett, 2008,259(1):111-118.
7. Qu X, Liu Y, Ma Y, et al. Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation [J]. Biochem Biophys Res Commun, 2008,367(1):183-189.
8. Barancík M, Bohácová V, Sedlák J, et al. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance [J]. Eur J Pharm Sci, 2006,29(5):426-434.